Dendreon Rises After Winning Approval for Cancer Drug (Update2)
April 29 (Bloomberg) — Dendreon Corp. won approval for its first product, a vaccine to fight prostate cancer, after a three-year battle with U.S. regulators. Shares surged the most in a year in New York trading.
Read more on Bloomberg
Blood Test for Lung Cancer in the Works
Title: Blood Test for Lung Cancer in the Works Category: Health News Created: 1/15/2010 10:51:00 AM Last Editorial Review: 1/15/2010 10:51:40 AM
Read more on MedicineNet.com
The best “treatment” for cancer is to prevent it from occurring. Research is ongoing to evaluate environmental and lifestyle factors that may be associated with an increased incidence of cancer. Identifying such risk factors may allow individuals to modify lifestyle choices in order to reduce their risk of developing cancer.
The Million Women Study in the United Kingdom involved over 1.3 million middle-aged women who responded to a questionnaire regarding sociodemographic and personal information, including alcohol consumption. These women were followed for several years in an effort to determine how reproductive and lifestyle factors affect women’s health.
» Read more: Terramed Alliance News Moderate Alcohol Consumption Increases Risk of Cancer in Women